$Zomedica (ZOM.US)$The financial report will be released after the market on November 7. Investors stay tuned.
What was the previous performance?
$Zomedica (ZOM.US)$2024/Q2 operating income of $6.131 million, net profit of $22.91 million, and earnings per share of -$0.024.
2023/Q3 operating income of $6.347 million, net profit of $-0.491 million, and earnings per share of $0.001.
The accounting standard for the above data is US_GAAP.
Futubull tips:
1. There is no hard rule on the division of the fiscal year for Hong Kong stock and US stock listed companies; it is entirely up to the enterprise to decide. Therefore, each financial reporting period can be used as the enterprise's annual report deadline, rather than the natural year as the fiscal year.
2. Generally speaking, the company will hold a financial report meeting on or near the above financial report release date. At that time, the company management will discuss and explain the latest quarter's financial data and operations, and communicate with investors, analysts, media, etc.
Investors can participate through offline meetings or online conference calls.